Orion Pharma (DHA:ORIONPHARM) Total Liabilities : BDT32,293 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Total Liabilities?

Orion Pharma's Total Liabilities for the quarter that ended in Mar. 2025 was BDT32,293 Mil.

Orion Pharma's quarterly Total Liabilities increased from Sep. 2024 (BDT31,213.07 Mil) to Dec. 2024 (BDT31,766.76 Mil) and increased from Dec. 2024 (BDT31,766.76 Mil) to Mar. 2025 (BDT32,292.95 Mil).

Orion Pharma's annual Total Liabilities increased from Jun. 2022 (BDT27,338.18 Mil) to Jun. 2023 (BDT30,605.63 Mil) but then declined from Jun. 2023 (BDT30,605.63 Mil) to Jun. 2024 (BDT30,102.66 Mil).

Orion Pharma Total Liabilities Historical Data

The historical data trend for Orion Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Total Liabilities Chart

Orion Pharma Annual Data

Trend

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Liabilities

Get a 7-Day Free Trial

17,651.40

22,258.68

27,338.18

30,605.63

30,102.66

Orion Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															29,028.89	30,102.66	31,213.07	31,766.76	32,292.95

Orion Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Orion Pharma's Total Liabilities for the fiscal year that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7766.386	+	(21877.435	+	458.838
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	30,103

Total Liabilities	=	Total Assets (A: Jun. 2024 )	-	Total Equity (A: Jun. 2024 )
	=	53185.508	-	23082.849
	=	30,103

Orion Pharma's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8600.429	+	(23169.261	+	523.255
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	32,293

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	54652.296	-	22359.351
	=	32,293

Orion Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208

Website

https://www.orionpharmabd.com

Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines